report published by Value Market Research, which studies the future outlook of the market. It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2022-2028.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the opioids use disorder market include Alkermes Inc., AstraZeneca plc, BioDelivery Sciences International Inc., Braeburn Pharmaceuticals, Camurus, Dr Reddy Laboratories Ltd, Pear Therapeutics, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, NYC Health Hospitals, Orexo AB, OREXO AB, Indivior PLC, Reckitt Benckiser Pharmaceuticals Inc, Sandoz, Titan Pharmaceuticals Inc., Viatris Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
The global opioids use disorder market is set to gain traction from the surging adoption of buprenorphine treatment patches for treating opioid addiction. The major factor fueling the market growth of opioid use disorder is the increase in the number of patients suffering from chronic pain. Moreover, the increase in the prevalence of chronic diseases such as cancer, injuries, and cardiovascular globally is fueling the growth of the opioid use disorder market. In addition, an increase in healthcare spending, an increase in research funds, and an increase in research and development activities are all positively influencing the opioid use disorder market. However, limited product availability is expected to obstruct market growth.
Opioids use disorder (OUD) refers to a condition in which patients are addicted/dependent on the consumption of opioids and is generally caused by environmental and genetic factors. Opioids use disorder is segregated into two categories, including opioids available as non-medicinal and patients reliant on medicinal opioid drugs. Opioids use disorder is an ongoing condition related to urgent, delayed, and rehashed consumption of opioids. Opioids use disorder is typically a chronic, relapsing illness associated with significantly increased morbidity and mortality rates.
This section of the opioids use disorder market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug Type
· Agonist (Type (Methadone, Buprenorphine))
By Age Group
· 19 To 39
· 40 To 59
· Age 60 And Over
By Route Of Administration
By Distribution Channal
· Hospital Pharmacy
· Retail Pharmacy
Browse Global Opioids Use Disorder Market Research Report with detailed TOC at
This section covers the regional outlook, which accentuates current and future demand for the Opioids Use Disorder market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Want to print your doc? This is not the way.
Try clicking the ⋯ next to your doc name or using a keyboard shortcut (